קלוטריזון

Country: Իսրայել

language: եբրայերեն

source: Ministry of Health

active_ingredient:

BETAMETHASONE DIPROPIONATE; CLOTRIMAZOLE

MAH:

TARO PHARMACEUTICAL INDUSTRIES LTD

ATC_code:

D07XC01

pharmaceutical_form:

קרם

composition:

CLOTRIMAZOLE 1 %W/W; BETAMETHASONE DIPROPIONATE 0.064 %W/W

administration_route:

חיצוני

prescription_type:

מרשם נדרש

manufactured_by:

TARO PHARMACEUTICAL INDUSTRIES LTD

therapeutic_group:

BETAMETHASONE

therapeutic_area:

BETAMETHASONE

therapeutic_indication:

Clotrimazole and Betamethasone Dipropionate cream, are indicated for the topical treatment of the following dermal infections: tinea pedis, tinea cruris, and tinea corporis due to Trichophyton rubrum, Trichophyton mentagrophytes, Epidermophyton floccosusm.

authorization_date:

2022-07-31